Fundraising Fox
Oral Genome
Carlsbad, US · Founded 2021 · Delaware corporation · 2 known investors
Find your way into Oral Genome
Sign up to see every warm intro you have to Oral Genome
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oral Genome team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oral Genome offers a saliva-based, point-of-care testing platform that uses a smartphone app to analyze a test card and identify oral and whole-body health risk indicators within minutes. It is designed for dental, medical, institutional, and individual use across clinical, public-health, and community settings.
Founders & leadership
Oral Genome was founded in 2021 by Dr. Tina Saw.
DT
Dr. Tina SawChief Executive Officer
TL
Thanh LuuNamed on SEC filing
Board
TP
Tim PrangerBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$3.2M disclosed across 4 rounds · 2021–2025
▶$3.1MraisedJan 2025 · 37 investors · BiotechnologyRule 506(b)
▶$3.1MraisedJan 2025 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tim PrangerDirector
- Tina SawExecutive Officer, Director
- Offering amount
- $5.1M
- Amount sold
- $3.1M
- Proceeds to insiders
- $100K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$75KraisedNov 2022 · 1 investors · Other Health CareRule 506(c)
▶$75KraisedNov 2022 · 1 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Thanh LuuExecutive Officer, Director
- Tina SawExecutive Officer, Director
- Offering amount
- $75K
- Amount sold
- $75K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06c
▶$13.1KraisedApr 2022 · 1 investors · Other Health CareRule 506(c)
▶$13.1KraisedApr 2022 · 1 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Thanh LuuExecutive Officer, Director
- Tina SawExecutive Officer, Director
- Offering amount
- $13.1K
- Amount sold
- $13.1K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06c
▶$30KraisedNov 2021 · 1 investors · Other Health CareRule 506(c)
▶$30KraisedNov 2021 · 1 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Tina SawExecutive Officer, Director
- Thanh LuuExecutive Officer, Director
- Offering amount
- $30K
- Amount sold
- $30K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
DentuluDentulu is a virtual dental care platform that connects patients with licensed US-based dentists for video consultations, second opinions, and e-prescriptions, alongside at-home tools such as intraoral cameras (MouthCAM), salivary testing kits, AI image analysis, and home sleep apnea testing. It serves patients seeking preventive and remote dental care and coordinates referrals to local clinics and specialists for in-person treatment.
Viome Life SciencesViome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations. The direct-to-consumer service, analyzed in a CLIA-certified lab, is aimed at individuals seeking insights into digestion, metabolism, and overall wellness.
Rupa HealthA platform that enables healthcare providers to order, track, and receive lab test results from multiple laboratory companies through a single dashboard, supporting both in-person and telehealth patients with flexible billing options and EHR integration.
BristleBristle provides digital tools and insights to help people assess and improve their oral health, positioning dental care as a preventive step toward overall wellness.
Nebula GenomicsNebula Genomics offers whole genome sequencing, providing consumers with health, trait, ancestry, and oral microbiome reports based on 100% of their DNA. Its DNA Complete product delivers 350+ personalized genetic reports across categories such as cardiovascular health, brain health, and wellness.
Companies working in the same space as Oral Genome.
Frequently asked questions
- What does Oral Genome do?
- Oral Genome offers a saliva-based, point-of-care testing platform that uses a smartphone app to analyze a test card and identify oral and whole-body health risk indicators within minutes. It is designed for dental, medical, institutional, and individual use across clinical, public-health, and community settings.
- Who founded Oral Genome?
- Oral Genome was founded by Dr. Tina Saw in 2021.
- Who are Oral Genome's investors?
- Oral Genome's investors include Health Wildcatters, R/GA Ventures.
- How much funding has Oral Genome raised?
- Oral Genome has disclosed $3.2M raised across 4 rounds.
- Where is Oral Genome headquartered?
- Oral Genome is headquartered in Carlsbad, US.